Anthonie J. Zwijnenburg

ORCID: 0000-0003-3150-0190
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • T-cell and B-cell Immunology
  • Chemokine receptors and signaling
  • Immunotherapy and Immune Responses
  • Atherosclerosis and Cardiovascular Diseases
  • Immune Cell Function and Interaction
  • Immune responses and vaccinations
  • CAR-T cell therapy research
  • Immunodeficiency and Autoimmune Disorders

Karolinska Institutet
2019-2023

Karolinska University Hospital
2019-2023

Harvard University
2016

T cells differentiate into functionally distinct states upon antigen encounter. These are delineated by different cell surface markers for murine and human cells, which hamper cross-species translation of properties. We aimed to identify that reflect the graded nature CD8+ differentiation delineate comparable in mice humans. CITEseq analyses revealed expression CX3CR1, encoding chemokine receptor correlated with gradient. CX3CR1 distinguished CD4+ states, as defined migratory functional...

10.1016/j.immuni.2023.06.025 article EN cc-by Immunity 2023-07-24

Expression levels of the chemokine receptor CX3CR1 serve as high-resolution marker delineating functionally distinct antigen-experienced T-cell states. The factors that influence expression in T cells are, however, incompletely understood. Here, we show vitro priming naïve CD8

10.1002/eji.202350658 article EN cc-by European Journal of Immunology 2023-10-10

Abstract CD8 T cells are crucial for the protection against tumors and intracellular pathogens via their ability to generate long-term memory. Memory (TMem) however not a homogenous population. Traditionally, blood-borne TMem have been sub-divided into central memory (TCM) effector (TEM) based on different migration behaviors cytotoxic potential. We recently discovered existence of novel subset that has unique migratory properties superior homeostatic self-renewal capacity. The hitherto...

10.1158/2326-6066.imm2016-a057 article EN Cancer Immunology Research 2016-10-31
Coming Soon ...